Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gynecologic melanomas: A clinicopathologic and molecular analysis.
Udager AM, Frisch NK, Hong LJ, Stasenko M, Johnston CM, Liu JR, Chan MP, Harms PW, Fullen DR, Orsini A, Thomas DG, Lowe L, Patel RM. Udager AM, et al. Among authors: johnston cm. Gynecol Oncol. 2017 Nov;147(2):351-357. doi: 10.1016/j.ygyno.2017.08.023. Epub 2017 Aug 24. Gynecol Oncol. 2017. PMID: 28844540
Vulvar melanoma: a report of 20 cases and review of the literature.
Wechter ME, Gruber SB, Haefner HK, Lowe L, Schwartz JL, Reynolds KR, Johnston CM, Johnson TM. Wechter ME, et al. Among authors: johnston cm. J Am Acad Dermatol. 2004 Apr;50(4):554-62. doi: 10.1016/j.jaad.2003.07.026. J Am Acad Dermatol. 2004. PMID: 15034504 Review.
Vulvar melanoma: review of diagnosis, staging, and therapy.
Wechter ME, Reynolds RK, Haefner HK, Lowe L, Gruber SB, Schwartz JL, Johnston CM, Johnson TM. Wechter ME, et al. Among authors: johnston cm. J Low Genit Tract Dis. 2004 Jan;8(1):58-69. doi: 10.1097/00128360-200401000-00012. J Low Genit Tract Dis. 2004. PMID: 15874838
A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study.
Monk BJ, Kauderer JT, Moxley KM, Bonebrake AJ, Dewdney SB, Secord AA, Ueland FR, Johnston CM, Aghajanian C. Monk BJ, et al. Among authors: johnston cm. Gynecol Oncol. 2018 Dec;151(3):422-427. doi: 10.1016/j.ygyno.2018.10.001. Epub 2018 Oct 8. Gynecol Oncol. 2018. PMID: 30309721 Free PMC article. Clinical Trial.
A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group study.
Coleman RL, Sill MW, Thaker PH, Bender DP, Street D, McGuire WP, Johnston CM, Rotmensch J. Coleman RL, et al. Among authors: johnston cm. Gynecol Oncol. 2015 Jul;138(1):30-5. doi: 10.1016/j.ygyno.2015.04.005. Epub 2015 Apr 14. Gynecol Oncol. 2015. PMID: 25887099 Free PMC article. Clinical Trial.
127 results